Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30120% above fair value
$17.22−0.15 (-0.86%)
Close on Nov 19, 2026Market cap $470.15MP/E –Yield –
Carlsmed net income
Net income is the profit left for shareholders after every expense, interest and tax.
Carlsmed's net income for the twelve months ending Jun 30, 2026 was -$36.35M. For fiscal 2025 it was -$29.63M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.63M | – |
| FY2024 | Dec 31, 2024 | -$24.26M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.51M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.70M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.61M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.77M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.72M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.81M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.45M | – |
See a number that looks wrong?